CIK 0001820190 · <br>Emerging growth company
Scilex Holding Co
Sign in to watch- Ticker
- SCLX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (650) 516-4310
- Business address
- 960 SAN ANTONIO ROAD, PALO ALTO, CA, 94303
- Former names
- Scilex Holding Company/DE, Vickers Vantage Corp. I
Securities
- SCLX Common Stock Nasdaq
- SCLXW Warrant Nasdaq
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-06-18 | Ji Henry Executive Chairperson | Option exercise · Nonstatutory Stock Option (right to buy) | −6,000 | 194,000 | ||
| 2024-06-14 | SHAH JAISIM See Remarks | Option exercise | +33,333 | $1.41 | $47K | 33,333 |
| 2024-06-14 | SHAH JAISIM See Remarks | Option exercise · Nonstatutory Stock Option (right to buy) | −33,333 | 166,667 | ||
| 2024-05-17 | Ji Henry Executive Chairperson | Purchase | +50,000 | $0.88 | $44K | 50,070 |
| 2024-05-17 | Chun Jay Director | Purchase | +57,500 | $0.90 | $52K | 102,500 |
| 2024-05-17 | SHAH JAISIM See Remarks | Purchase | +56,939 | $0.92 | $52K | 155,882 |
| 2024-05-17 | Ma Stephen Hoi Chief Financial Officer | Purchase | +14,140 | $0.88 | $12K | 14,140 |
| 2024-05-16 | SHAH JAISIM See Remarks | Purchase | +83,061 | $0.84 | $70K | 98,943 |
| 2024-03-15 | Lemus David Director | Grant or award · Nonstatutory Stock Option (right to buy) | +100,000 | 100,000 | ||
| 2024-03-15 | Followwill Dorman Director | Grant or award · Nonstatutory Stock Option (right to buy) | +100,000 | 100,000 | ||
| 2023-10-04 | Ji Henry Executive Chairperson | Grant or award · Nonstatutory Stock Option (right to buy) | +200,000 | 200,000 | ||
| 2023-10-04 | SHAH JAISIM See Remarks | Grant or award · Nonstatutory Stock Option (right to buy) | +200,000 | 200,000 | ||
| 2023-10-04 | Wu Yue Alexander Director | Grant or award · Nonstatutory Stock Option (right to buy) | +250,000 | 250,000 | ||
| 2023-10-04 | Chun Jay Director | Grant or award · Nonstatutory Stock Option (right to buy) | +250,000 | 250,000 | ||
| 2023-10-04 | Ma Stephen Hoi Chief Financial Officer | Grant or award · Nonstatutory Stock Option (right to buy) | +150,000 | 150,000 | ||
| 2023-09-21 | Sorrento Therapeutics, Inc. 10% owner | Sale | −60,068,585 | 1,917,210 | ||
| 2023-09-21 | Sorrento Therapeutics, Inc. 10% owner | Sale · Warrants to Purchase Common Stock | −4,490,617 | 0 | ||
| 2023-03-17 | Ji Henry Executive Chairperson | Other acquisition | +2,730 | $8.60 | $23K | 2,730 |
| 2023-01-19 | Sorrento Therapeutics, Inc. 10% owner | Other disposition | −73,740,795 | 61,985,795 | ||
| 2023-01-17 | Followwill Dorman Director | Grant or award · Nonstatutory Stock Option (right to buy) | +250,000 | 250,000 |
Page 3 of 4 · 75 trades